By Tom Randall Pfizer Inc. (PFE)’s pneumonia vaccine, the company’s fastest-growing drug by sales, was found effective in two studies of adults over the age of 50, supporting the company’s regulatory application to expand the product’s use. The vaccine, Prevnar 13, produced a stronger immune response against pneumococcal bacteria than an older vaccine from Merck […]
FDA: Infants May Get Meningococcal Vaccine
By Joyce Frieden, News Editor, MedPage Today WASHINGTON — The FDA has approved the first meningococcal vaccine for use in toddlers and infants as young as nine months of age. The vaccine, called Menactra, is already approved for use in people ages 2 through 55 for prevention of invasive meningococcal disease caused by Neisseria meningitidis […]
HPV Vaccine Study May Help Women in Developing Countries
By Katherine Rausch HPV vaccine may be effective provided over longer periods of time, according to new research, which can benefit women in developing countries. HPV is a sexually transmitted infection that is the primary cause of cervical cancer in women. A new study found adolescent girls who took the vaccine over a longer time […]
SaneVax Presents: Global Concerns About HPV Vaccines – Fact Sheet
The SaneVax Team has put together an easy to read fact sheet for health advocates worldwide. This document succinctly states facts about HPV infections and HPV vaccine safety and efficacy. Please feel free to distribute as necessary to those who need more information about HPV vaccines. Global Concerns – HPV Vaccine Fact Sheet
HPV Vaccination — More Answers, More Questions
George F. Sawaya, M.D., and Karen Smith-McCune, M.D., Ph.D. N Engl J Med 2007; 356:1991-1993May 10, 2007 The availability of a “cancer vaccine” has elicited enormous enthusiasm from the medical community and the public, culminating in advocacy for mandatory vaccination against human papillomavirus (HPV) and a recommendation from the Centers for Disease Control and Prevention […]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- Next Page »
